Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway

被引:0
作者
Gouni-Berthold I. [1 ]
Berthold H.K. [1 ]
Weber A.-A. [2 ]
Ko Y. [1 ]
Seul C. [1 ]
Vetter H. [1 ]
Sachinidis A. [1 ]
机构
[1] Medizinische Universitats-Poliklinik, 53111 Bonn
[2] Institut fur Pharmakologie, Heinrich-Heine-Universitat Dusseldorf, Dusseldorf
关键词
Apoptosis; Oral antidiabetics; Oral hypoglycemic agents; Peroxisome proliferator-activated receptor γ; Rosiglitazone; Signal-regulated response kinases; Smooth muscle; Thiazolidinediones; Troglitazone;
D O I
10.1007/s002100000352
中图分类号
学科分类号
摘要
Recent evidence suggests that apoptosis may be involved in the control of vascular smooth muscle cell (VSMC) number in atherosclerotic lesions. The peroxisome proliferator-activated receptor γ (PPARγ) ligands thiazolidinediones have been reported to induce apoptosis in macrophages and in a variety of tumor cell lines. To evaluate whether these agents also induce apoptosis in VSMC, cultured rat VSMC were treated with increasing doses of the thiazolidinedione analogues troglitazone (TRO) and rosiglitazone (RSG). Both ligands induced cell death in a (concentration-dependent manner (EC)50 (12.1±3.3) μM and 1.43±0.39 μM, respectively), causing almost complete cell death at the highest concentrations (100 μM and 10 μM for TRO and RSG, respectively), along with an expected parallel decrease in [3H]thymidine uptake into cell DNA (EC)50 6.7±2.4 μM and 0.75±0.19 μM, respectively). The cell count was determined by the coulter counter principle. Furthermore two apoptotic markers were measured, the caspase 3 activity and the cytoplasmic histone-associated DNA fragments, both of which were significantly increased when the aforementioned high concentrations were used. This indicates that apoptosis is involved in the TRO- and RSG-induced VSMC growth suppression. The same concentrations of TRO and RSG caused an unexpected stimulation of the extracellular signal-regulated response kinases 1 and 2 (ERK1/2) and stimulated the p38 mitogenic-activated protein (MAP) kinase as determined by Western blotting. In order to establish whether the proapoptotic effects of TRO and RSG are mediated through ERK1/2 activation, we used the selective MAP kinase kinase (MEK) inhibitor PD98059 (20 μM), which suppressed the TRO- and RSG-induced ERK1/2 activation but did not abolish their proapoptotic effects. We conclude that the thiazolidinedione analogues TRO and RSG induce cell death due to apoptosis in VSMC through an ERK1/2-independent pathway.
引用
收藏
页码:215 / 221
页数:6
相关论文
共 31 条
  • [1] Bennett M.R., Boyle J.J., Apoptosis of vascular smooth muscle cells in atherosclerosis, Atherosclerosis, 138, pp. 3-9, (1998)
  • [2] Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A., Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures, Proc Natl Acad Sci USA, 92, pp. 7162-7166, (1995)
  • [3] Bradford M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem, 72, pp. 248-254, (1976)
  • [4] Brockman J.A., Gupta R.A., Dubois R.N., Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells, Gastroenterology, 115, pp. 1049-1055, (1998)
  • [5] Chamley-Campbell J., Campbell G.R., Ross R., The smooth muscle cell in culture, Physiol Rev, 59, pp. 1-61, (1979)
  • [6] Chinetti G., Griglio S., Antonucci M., Torra I.P., Delerive P., Majd Z., Fruchart J.C., Chapman J., Najib J., Staels B., Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages, J Biol Chem, 273, pp. 25573-25580, (1998)
  • [7] Dubey R.K., Zhang H.Y., Reddy S.R., Boegehold M.A., Kotchen T.A., Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats, Am J Physiol, 265, pp. R726-R732, (1993)
  • [8] Elstner E., Muller C., Koshizuka K., Williamson E.A., Park D., Asou H., Shintaku P., Said J.W., Heber D., Koeffler H.P., Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice, Proc Natl Acad Sci USA, 95, pp. 8806-8811, (1998)
  • [9] Fanger G.R., Gerwins P., Widmann C., Jarpe M.B., Johnson G.L., MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: Upstream regulators of the c-Jun amino-terminal kinases?, Curr Opin Genet Dev, 7, pp. 67-74, (1997)
  • [10] Fujimura S., Suzumiya J., Nakamura K., Ono J., Effects of troglitazone on the growth and differentiation of hematopoietic cell lines, Int J Oncol, 13, pp. 1263-1267, (1998)